Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study
- 9 July 2015
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 46 (4) , 1205-1207
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in ChinaEuropean Respiratory Journal, 2014
- Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?European Respiratory Journal, 2013
- Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patientsEuropean Respiratory Journal, 2013
- Linezolid for Treatment of Chronic Extensively Drug-Resistant TuberculosisNew England Journal of Medicine, 2012
- Efficacy and safety of meropenem–clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TBEuropean Respiratory Journal, 2012
- Linezolid: safety and efficacy monitoringEuropean Respiratory Journal, 2012
- Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysisEuropean Respiratory Journal, 2012
- Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis [Review article]The International Journal of Tuberculosis and Lung Disease, 2012
- Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in IndiaEuropean Respiratory Journal, 2011
- Comparison of the Pharmacokinetics of Two Dosage Regimens of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis PatientsClinical Pharmacokinetics, 2010